Calreticulin levels determine onset of early muscle denervation by fast motoneurons of ALS model mice

Neurobiol Dis. 2015 Jan:73:130-6. doi: 10.1016/j.nbd.2014.09.009. Epub 2014 Sep 30.

Abstract

Although the precise signaling mechanisms underlying the vulnerability of some sub-populations of motoneurons in ALS remain unclear, critical factors such as metallo-proteinase 9 expression, neuronal activity and endoplasmic reticulum stress have been shown to be involved. In the context of SOD1(G93A) ALS mouse model, we previously showed that a two-fold decrease in calreticulin (CRT) is occurring in the vulnerable fast motoneurons. Here, we asked to which extent the decrease in CRT levels was causative to muscle denervation and/or motoneuron degeneration. Toward this goal, a hemizygous deletion of the crt gene in SOD1(G93A) mice was generated since the complete ablation of crt is embryonic lethal. We observed that SOD1(G93A);crt(+/-) mice display increased and earlier muscle weakness and muscle denervation compared to SOD1(G93A) mice. While CRT reduction in motoneurons leads to a strong upregulation of two factors important in motoneuron dysfunction, ER stress and mTOR activation, it does not aggravate motoneuron death. Our results underline a prevalent role for CRT levels in the early phase of muscle denervation and support CRT regulation as a potential therapeutic approach.

Keywords: ALS; Calreticulin; ER stress; Muscle weakness and denervation; mTOR.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activating Transcription Factor 6 / metabolism
  • Age Factors
  • Amyotrophic Lateral Sclerosis / complications*
  • Amyotrophic Lateral Sclerosis / genetics
  • Amyotrophic Lateral Sclerosis / pathology
  • Animals
  • Calreticulin / genetics
  • Calreticulin / metabolism*
  • Disease Models, Animal
  • Eukaryotic Initiation Factor-2 / metabolism
  • Gene Expression Regulation / genetics*
  • Mice
  • Mice, Transgenic
  • Motor Neurons / metabolism
  • Motor Neurons / pathology*
  • Muscle Weakness / etiology
  • Muscular Diseases / etiology*
  • Muscular Diseases / pathology
  • Nerve Degeneration / etiology*
  • Receptors, Cholinergic / metabolism
  • Spinal Cord / pathology
  • Superoxide Dismutase / genetics
  • TOR Serine-Threonine Kinases
  • Vesicular Acetylcholine Transport Proteins / metabolism

Substances

  • Activating Transcription Factor 6
  • Atf6 protein, mouse
  • Calreticulin
  • Eukaryotic Initiation Factor-2
  • Receptors, Cholinergic
  • Slc18a3 protein, mouse
  • Vesicular Acetylcholine Transport Proteins
  • SOD1 G93A protein
  • Superoxide Dismutase
  • mTOR protein, mouse
  • TOR Serine-Threonine Kinases